Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-005996
Filing Date
2017-01-27
Accepted
2017-01-27 18:08:08
Documents
1
Period of Report
2017-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4143
  Complete submission text file 0001209191-17-005996.txt   5532
Mailing Address ARYX THERAPEUTICS,INC. 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address
Nagler David (Reporting) CIK: 0001416175 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37833 | Film No.: 17555029

Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Issuer) CIK: 0001628738 (see all company filings)

EIN.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)